Membrane interactions and photodynamic activity of 1,9-dimethyl methylene blue in oropharyngeal carcinoma models

L G Moreira1, M B Kobal1, S A Camacho1

  • 1São Paulo State University (UNESP), School of Sciences, Humanities and Languages, Assis, SP 19806-900, Brazil.

Insights

1,9-dimethyl methylene blue (DMMB) shows promise as a photodynamic therapy agent for oropharyngeal cancer. Its effectiveness in disrupting cancer cell membranes increases with higher concentrations and light doses, indicating potential for targeted treatment.

Area of Science:

  • Biophysics
  • Photochemistry
  • Cancer Research

Background:

  • Photodynamic therapy (PDT) is an emerging cancer treatment requiring photosensitizing agents (PSs).
  • Phenothiazine derivatives are effective PSs, with 1,9-dimethyl methylene blue (DMMB) showing potential for anticancer applications.
  • The photodynamic effects of DMMB on oropharyngeal carcinoma, especially concerning PS concentration and light dose, require further investigation.

Purpose of the Study:

  • To investigate the molecular interactions and photodynamic effects of DMMB on oropharyngeal carcinoma.
  • To evaluate the influence of DMMB concentration and light dose on its photodynamic efficacy.
  • To correlate DMMB-membrane interactions with cellular phototoxicity in oropharyngeal cancer models.

Main Methods:

  • Utilized membrane-mimetic systems (Langmuir monolayers and Langmuir-Schaefer films) from human oropharyngeal carcinoma cell (HEp-2) lipid extracts.
  • Employed Langmuir trough and FTIR spectroscopy to analyze DMMB-lipid interactions.
  • Conducted in vitro cellular assays (MTT and LDH) and confocal fluorescence microscopy to assess phototoxicity and cellular damage.

Main Results:

  • DMMB exhibited strong membrane affinity, causing significant monolayer expansion and altering elastic properties.
  • Photoactivation of DMMB induced concentration- and light dose-dependent reductions in monolayer surface area, indicating membrane damage.
  • Cellular assays confirmed DMMB's phototoxicity against HEp-2 cells, with reduced IC50 values at higher light doses and no dark toxicity; plasma membrane disruption was observed.

Conclusions:

  • DMMB demonstrates significant membrane interaction and photodynamic effects relevant to oropharyngeal carcinoma treatment.
  • The photodynamic efficacy of DMMB is modulated by photosensitizer concentration and light dose, suggesting a tunable therapeutic approach.
  • DMMB is a promising candidate for further development in oropharyngeal carcinoma photodynamic therapy.

Related Concept Videos